Showing results (2281-2290 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|June 8, 2001
Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxelR Bruno, N Vivier, C Veyrat-Follet, et al.Investigational New Drugs|June 8, 2001
Body surface area as a determinant of pharmacokinetics and drug dosingM Sawyer, M J RatainInvestigational New Drugs|November 18, 2000
The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potentialP M HoffInvestigational New Drugs|January 1, 1983
High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumorsC F LeMaistre, W A KnightInvestigational New Drugs|January 1, 1983
Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group studyJ C Arseneau, B Bundy, H Homesley, et al.Investigational New Drugs|January 1, 1994
Phase II study of low dose cyclophosphamide and intravenous interleukin-2 in metastatic renal cancerW D Quan, G E Dean, G Lieskovsky, et al.Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.Investigational New Drugs|January 1, 1994
Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group studyA Hantel, C Tangen, W L Gluck, et al.Investigational New Drugs|January 1, 1994
Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDRM Mariani, L Capolongo, A Suarato, et al.Investigational New Drugs|January 1, 1994
Phase I/II trial of dipyridamole, 5-fluorouracil, leukovorin, and mitoxantrone in metastatic breast cancerG T Budd, P Herzog, R M BukowskiPageof 372